Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor cachexia--a special entity and therapeutic sequelae]

M Heberer1

  • 1Forschungsabteilung des Departments Chirurgie, Kantonsspital, Universität Basel.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation.

Angiogenesis·2018
Same author

Governance of hospital alliances: lessons learnt from 6 hospital and non-hospital cases.

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2013
Same author

Perspective on the evolution of cell-based bone tissue engineering strategies.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2012
Same author

Immunohistochemical detection of MAGE tumor-associated antigens in esophageal squamous cell carcinoma.

Oncology reports·2011
Same author

[Patients as customers: risks and opportunities of a modified perception of in-hospital patients].

Deutsche medizinische Wochenschrift (1946)·2010
Same author

[From pay-for-effort to pay-for-performance--an analysis of the Swiss health care system with focus on the inpatient sector].

Praxis·2009

Cancer cachexia, a wasting syndrome, affects patients across terminal cancer stages. Management involves nutrition, medications like progesterone analogues and metoclopramide, with research exploring prophylactic interventions.

Area of Science:

  • Oncology
  • Metabolism
  • Palliative Care

Context:

  • Cancer cachexia is a complex syndrome characterized by generalized host tissue wasting.
  • It arises from the interplay between the tumor, the host, and cancer treatments.
  • This condition is observed across all terminal cancer stages and is not specific to any particular tumor type.

Purpose:

  • To outline a therapeutic algorithm for managing cancer cachexia.
  • To highlight the importance of addressing weight loss, functional impairment, and reduced quality of life.
  • To introduce the potential for innovative prophylactic interventions.

Summary:

  • Cancer cachexia involves significant tissue wasting due to tumor-host interactions and treatments.
  • Key symptoms include weight loss, functional decline, and diminished quality of life, necessitating palliative care.

Related Experiment Videos

  • A proposed therapeutic approach integrates parenteral/enteral nutrition, progesterone analogues, and metoclopramide.

    • Impact:

    • Provides a structured approach to palliative care for cancer cachexia.
    • Emphasizes the need for multidisciplinary management strategies.
    • Highlights ongoing research into novel prophylactic treatments for this debilitating condition.